The metabolic syndrome: A call to action

Coronary Artery Disease

Volumn 17, Issue 1, 2006, Pages 77-80

  Gotto, Antonio M ^a   Blackburn, George L ^b,c   Dailey, George E ^d   Garber, Alan J ^e   Grundy, Scott M ^f   Sobel, Burton E ^g   Weir, Matthew R ^h  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d SCRIPPS CLINIC   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular risk; Metabolic syndrome; Prevention

Indexed keywords

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL PRACTICE; HUMAN; MEDICAL RESEARCH; METABOLIC SYNDROME X; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSICIAN; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; CARDIOVASCULAR DISEASE; HEALTH; RISK FACTOR;

CARDIOVASCULAR DISEASES; HUMANS; METABOLIC SYNDROME X; PREVALENCE; RISK FACTORS; WORLD HEALTH;

EID: 33646968804     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200602000-00013     Document Type: Review

References (21)

1. Reaven GM. Why Syndrome X? From Harold Himsworth to the insulin resistence syndrome. Cell Metab 2005; 1: 9-14.
2. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Executive summary. Circulation 2005; 112:e-publication.
3. Ford ES, Giles WH, Dietz WH. Prevalence of metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287:356-359.
4. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004; 110:380-385.
5. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24:683-689.
6. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288:2709-2716.
7. Spanheimer R. New challenges in caring for diabetic patients: primary care physicians can get caught in the middle. Postgrad Med 2004; 116:1651-1654.
8. Johnson LA. Study: Metabolic syndrome brings big costs. Available online at http://abcnews.go.com/Health/wireStory?id=735994 [Accessed 25 October 2005].
9. International Diabetes Foundation. Diabetes atlas, 2nd ed. International Diabetes Federation; 2003. Available online at www.eatlas.idf.org [Accessed 25 October 2005].
10. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet 2005; 366:1059-1062.
11. The IDF Consensus worldwide definition of the metabolic syndrome. Brussels Belgium: International Diabetes Federation.
12. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28:2289-2304.
13. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al., for the Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393-403.
14. Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, et al., for the Diabetes Prevention Program Research Group. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the diabetes prevention program randomized trial. Ann Intern Med 2005; 142:611-619.
15. Klein S, Sheard NF, Pi-Sunyer X, Daly A, Wylie-Rosett J, Kulkarni K, et al. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Am J Clin Nutr 2004; 80:257-263.
16. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 2005; 54:603-608.
17. Lebovitz HE, Banerji MA. Point: visceral adiposity is causally related to insulin resistance. Diabetes Care 2005; 28:2322-2325.
18. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004; 291:2847-2850.
19. Adriaanse MC, Snoek FJ. The psychological impact of screening for type 2 diabetes. Diabetes Metab Res Rev 2005; e-pub.
20. Hertz RP, Unger AN, Cornell JA, Saunders E. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med 2005; 165:2098-2104.
21. Klingman D, Williams SA, Benner JS, Smith TW, Ahn J, O'Donnell JC. Gauging the treatment gap in dyslipidemia: findings from the 1999-2000 National Health and Nutrition Examination Survey. Am Heart J 2005; 150:595-601.